Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Western Blot Products
  4. General Western Blot Reagents
  5. 502710830

Abcam VEGFA Peptide, Synthetic, Blocking Peptide, Human, 1 mg

Catalog No. 502710830
Encompass_Preferred
Change view
Click to view available options
Quantity:
1 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
50-271-0830 1 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 50-271-0830 Supplier Abcam Supplier No. AB461601MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Description

Synthetic blocking peptide for western blot applications with over 90% purity.

  • Protein Name: VEGFA
  • Form: Liquid
  • Purity: >90%
  • Tested Applications: BL
  • Storage Buffer: pH 6.75; Constituents: 0.87% Sodium chloride, 0.714% HEPES, 0.0584% EDTA, 0.001% Sorbitan monolaurate, ethoxylated

The product is subject to the following: Abcam Restricted Use Statement

Specifications

Target Molecule VEGFA (Human)
Concentration 1 mg/mL
Form Liquid
Label or Dye Unconjugated
Reactivity Human
Shipping Condition Blue Ice
Product Type Blocker and Diluent
Buffer 0.87% sodium chloride, 0.714% HEPES, 0.0584% EDTA, 0.001% sorbitan monolaurate, ethoxylated, pH6.75
Content And Storage Store at -20°C.
Formulation 0.87% Sodium chloride, 0.714% HEPES, 0.0584% EDTA, 0.001% Sorbitan monolaurate, ethoxylated, pH 6.75
Quantity 1 mg
For Use With (Application) Blocking
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.